MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » 7 medtech stories we missed this week: April 21, 2017

7 medtech stories we missed this week: April 21, 2017

By

sitting on rock in canyon
[Image from unsplash.com]
From new and renewed partnerships to FDA approvals, here are 7 medtech stories we missed this week but thought were still worth mentioning.

1. Life Spine receives FDA clearance for cervical spacer system

Life Spine announced in an April 19 press release that it has received FDA 510(k) clearance for its Plateau-C Ti Cervical Spacer System. The system uses Life Spine’s titanium surface technology, Osseo-Loc, that helps with potential bone growth. Plateau-C Ti also has additional graft windows to help with visibility in-situ and bone graft containment. It entered full-market release on April 3 this year.

2. Lifetrack Medical announces FDA approval for PACS for distributed radiology

Lifetrack Medical Systems announced the FDA approval of its LifeSys PACS for distributed radiology, according to an April 19 press release. Its platform is designed to expand the availability of high-quality medicine and simplify and speed the development of digital radiology while reducing costs and bringing high-quality diagnostic reporting to large populations who need it. The PACS system features patented RadNav technology that serves as a guidance system to radiologists through its decision support system and templates.

3. Physio-Control launches HeartSine samaritan 360p AED

Physio-Control announced in an April 19 press release that its HeartSine samaritan PAD 36op AED is now available in the U.S. after receiving FDA pre-market approval. The HeartSine samaritan PAD 360P measures cardiac rhythm and automatically delivers a shock to someone who has a sudden cardiac arrest to restore the heart to normal rhythm. The AED is user-friendly and provides easy-to-follow visual and audio prompts. If the system finds that a person needs shock delivery, it will deliver it automatically without the need for pressing a button.

4. Owlstone Medical, Mayo Clinic to develop colonoscopy evaluation tool

Owlstone Medical and Mayo Clinic announced a partnership in an April 19 press release. The two companies are developing a pre-endoscopic test to improve the effectiveness of colonoscopy tests. Owlstone’s FAMIS technology is currently in a clinical trial to evaluate how it performs as a rapid, point-of-care test to non-invasively assess the adequacy of bowel preparation prior to colonoscopy. Pilot study results showed that the company’s technology is able to rapidly and effectively identify patients who are not properly prepped for colonoscopy with 100% sensitivity and 80% specificity.

5. FDA clears first wireless home spirometer

Monitored Therapeutics announced in an April 18 press release that it has received FDA 510(k) clearance for its GoSpiro home spirometer, which is the first spirometer designed for at-home wireless use. It is designed to work with a variety of smartphones, tablets and PCs. It gathers diagnostic quality forced spirometry and slow spirometry with the same accuracy as hospital laboratory systems and can give immediate feedback to patients on the quality of their test performance.

6. Remedent and Condor ink dental distribution deal

Remedent announced that it has entered a distribution deal with Condor to launch and distribute its 3D dental scanner in North America, according to an April 10 press release. Condor specializes in dental CAD/CAM equipment. Remedent has started hiring the appropriate staff to bring Condor’s new oral scanner to market.

7. Clearflow and Getinge announce partnership renewal

Clearflow and Getinge have announced in an April 10 press release that they have decided to renew their partnership to promote the PleuraFlow Active Clearance Technology System. The strategic partnership involves selling the system in the U.S. to enhance the clinical and economic value proposition.

Here’s what we missed last week.

In case you missed it

RSS From Medical Design & Outsourcing

  • Lifecore Biomedical’s owner plans to go all-in on contract development and manufacturing
    Lifecore Biomedical parent company Landec Corp. (Nasdaq:LNDC) plans to take the subsidiary’s name, leadership and headquarters as its own and sell off food businesses to focus on contract development and manufacturing. Santa Maria, California-based Landec said it will rename itself as Lifecore Biomedical “in the near future” and change its Nasdaq ticker to LFCR. Landec… […]
  • COVID-19 immunity test developers at MIT seek diagnostic manufacturer
    MIT researchers have developed a device for predicting an individual’s COVID-19 immunity and are looking for a diagnostic company to get it manufactured in large numbers and approved by the FDA. The lateral flow test uses the same technology as at-home rapid antigen COVID-19 tests to measure neutralizing antibodies for SARS-CoV-2 in a blood sample,… […]
  • GE Healthcare picks AI imaging startups for inaugural Edison Accelerator
    GE Healthcare and Nex Cubed have selected seven companies focused on artificial-intelligence-augmented medical imaging for the first cohort of the Edison Accelerator in Canada. The companies will be matched with mentors and test their technologies with GE’s new Edison Digital Health Platform over the next three months. The program will end with innovation showcase presentations… […]
  • Boston Scientific whistleblower launches corruption investigation
    Boston Scientific (NYSE:BSX) is investigating claims that the company violated the U.S. Foreign Corrupt Practices Act in Vietnam. Marlborough, Massachusetts–based Boston Scientific disclosed receipt of a whistleblower’s allegations in its latest filing with the Securities and Exchange Commission. “In March 2022, the company received a whistleblower letter alleging Foreign Corrupt Practices Act violations in Vietnam.… […]
  • 5 essential leadership lessons from Cathy Burzik for medtech’s next generation of women leaders
    Cathy Burzik, a seasoned senior executive in the healthcare industry, has successfully led major medical device, diagnostic, diagnostic imaging and life sciences businesses. Cathy Burzik, CFB Interests (as told to MedExecWomen co-founder Maria Shepherd) One key to being a successful women leader in MedTech: “Play nice, but play to win.” Cathy Burzik, who received a… […]
  • Stratasys plans to buy Covestro’s additive manufacturing business
    Stratasys (Nasdaq:SSYS) said today that it has a deal to purchase the additive manufacturing materials business of Covestro. The deal includes R&D facilities and activities, global development and sales teams across Europe, the U.S. and China, a portfolio of approximately 60 additive manufacturing materials, and hundreds of patents and patents pending, Stratasys said in a… […]
  • New implant design prevents scar tissue without drugs, MIT says
    Mechanically inflating and deflating an implantable device for 10 minutes a day prevents immune cells from building the scar tissue that has been a major obstacle for artificial pancreas researchers. That’s according to new findings from a team of MIT engineers who built mechanical deflection into a two-chambered, soft polyurethane device tested on mice. By… […]
  • Blue Spark’s TempTraq catches fevers faster. Fever prediction is next.
    Blue Spark Technologies developed the first wireless continuous temperature monitor patch, TempTraq, to enable faster fever detection than standard manual readings every four hours. Westlake, Ohio-based Blue Spark is now looking at fever prediction rather than just detecting them. The R&D team is working on developing an AI neural network model built on the company’s… […]
  • Harvard researchers plan to sell at-home, PCR-grade COVID testing system
    The Harvard University researchers who developed an ultrasensitive, PCR-grade nucleic acid detection technology plan to commercialize it as a portable COVID-19 test. Harvard Medical School professor Peng Yin, who also leads the Wyss Institute for Biologically Inspired Engineering’s Molecular Robotics Initiative, founded 3EO Health to sell the device. “In order to optimize the value of… […]
  • FDA reports sterilization challenge progress as EPA takes aim at EtO emissions
    The FDA offered an update on its efforts to make medical device sterilization safer as the EPA identified 23 U.S. facilities where use of ethylene oxide (EtO) presents a risk to communities. The FDA said it is similarly concerned about unsafe EtO emissions and highlighted work with the medical device industry to reduce EtO usage… […]
  • AdvaMed defends EtO facilities on EPA’s cancer risk list
    The Advanced Medical Technology Association (AdvaMed) today reacted to the EPA’s listing of commercial sterilization facilities causing elevated risks of cancer with a defense of the facilities and a call for more research. AdvaMed CEO and President Scott Whitaker said all of the listed facilities are in compliance with regulations and warned against closures. “The… […]